WHO Grade 4 Glioma — Trials

WHO Grade 4 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

1,854 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 535
Recruiting: 286
Ph III recruiting: 15
Growth YoY: +41.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 101–119 of 119 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05909618	Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases(14)	recruiting	Phase 2	33	Sheba Medical CenterOTHER_GOV	1	Jul 22, 2025	clinicaltrials
NCT03175224	APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA)	recruiting	Phase 2	497	Apollomics Inc.INDUSTRY	11	Jun 27, 2025